Article Details
Retrieved on: 2021-08-30 15:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche withdrew its accelerated approval of Tecentriq for the treatment of a severe form of breast cancer in the U.S., after consultation with the FDA.
Article found on: www.marketscreener.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here